#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Narcolepsy Hepatic cirrhosis Indolent systemic mastocytosis Uveal melanoma Bronchopulmonary dysplasia Angiosarcoma Small cell lung cancer limited stage Liposarcoma metastatic Endocrine ophthalmopathy Frostbite Parkinson's disease Malignant fibrous histiocytoma Netherton's syndrome Cholangiosarcoma Liver transplant rejection More trials…

    Learn about Rare Diseases

    Mitochondrial myopathy – Trials in Disease Isodicentric chromosome 15 syndrome – Basic Information Lysosomal storage disorder Mantle cell lymphoma refractory Alveolar rhabdomyosarcoma – Treatment Pleomorphic leiomyosarcoma – Life with Disease Rhabdomyosarcoma recurrent – Life with Disease Chronic granulomatous disease – Trials in Disease Pemphigus Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexchlorpheniramine Maleate Lymecycline Nepafenac Fentanyl Elacestrant Dihydrochloride Pamapimod Tegoprubart Keto-Leucine Calcium Mezigdomide Rifabutin Vincristine Sulfate Arginine Hydrochloride Difelikefalin GLYCYL-TYROSINE Quercus Robur Pollen Extract Blu-451 Dorocubicel Lovo-B GSKVX000000040033 Potassium Oxybate More therapies…

    Learn about Your Condition

    Lung adenocarcinoma Meniere's disease Aplastic anaemia Hand dermatitis Giardiasis Embolism venous BK virus infection Medication overuse headache Anal cancer stage II Pathogen resistance Diabetes insipidus VEXAS syndrome Dyspnoea Endolymphatic hydrops Gastric cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Psoriatic arthropathy

  • Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Not Used Anti-TNF Therapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Tildrakizumab
    Czechia Germany Poland Spain

  • Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Bimekizumab
    Belgium Czechia France Germany Hungary Italy +2

  • Study on Deucravacitinib and Apremilast for Patients with Active Psoriatic Arthritis New to Biologic Treatments or Previously on TNFα Inhibitors

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Apremilast
    • Deucravacitinib
    Belgium Czechia Germany Hungary Poland Spain

  • Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Deucravacitinib
    Bulgaria Czechia Finland France Hungary Ireland +4

  • Study on Long-Term Safety and Efficacy of Tildrakizumab for Adults with Psoriatic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Tildrakizumab
    Czechia Estonia Germany Italy Poland Slovakia +1

  • Study on Izokibep for Improving Symptoms in Patients with Active Psoriatic Arthritis

    Not recruiting

    4 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Izokibep
    Bulgaria Czechia Germany Hungary Poland Spain
Previous Page
1 … 5 6 7 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!